SCHEMBL4958729

SCHEMBL4958729

CC(C)(C)c1ccc(C(COC(N)=O)c2nnn[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ALDH1A1 P00352 1/20 0.36
EPHX1 P07099 5/20 0.35
SCN10A Q9Y5Y9 2/20 0.35
KIF11 P52732 1/20 0.34
FFAR1 O14842 1/20 0.33
NR1H4 Q96RI1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960105 0.81 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL4960423 0.78 CYP1A2 (0.38) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL4962975 0.77 ALOX5 (0.46) FFAR1
SCHEMBL4960360 0.72 CYP1A2 (0.33) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL4962125 0.72 CYP1A2 (0.41) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL4959934 0.70 CYP1A2 (0.38) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL4958548 0.70 CES2 (0.35) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1
SCHEMBL15784717 0.65 AKT1 (0.36) SMN1; SMN2NR1H4
SCHEMBL17045281 0.65 EPHX2 (0.44) ALDH1A1EPHX1NR1H4
SCHEMBL4959908 0.65 ALDH1A1 (0.35) SMN1; SMN2CYP1A2CYP2D6PKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879873-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK Holdings Co., Ltd. (KR) 2008-01-23 EP disclosed
WO-2006112685-A1 NEUROTHERAPEUTIC AZOLE COMPOUNDS SK HOLDINGS CO., LTD. (KR) 2006-10-26 WO disclosed